University of Connecticut

OpenCommons@UConn
SoDM Masters Theses

School of Dental Medicine

June 1998

Expression and Distribution of Secretory Proteins
in the Rat Submandibular Gland in Experimental
Diabetes
Christopher Brett Clark

Follow this and additional works at: https://opencommons.uconn.edu/sodm_masters
Recommended Citation
Clark, Christopher Brett, "Expression and Distribution of Secretory Proteins in the Rat Submandibular Gland in Experimental
Diabetes" (1998). SoDM Masters Theses. 27.
https://opencommons.uconn.edu/sodm_masters/27

EXPRESSION AND DISTRIBUTION OF SECRETORY PROTEINS

IN THE RAT SUBMANDIBULAR GLAND
IN EXPERIMENTAL DIABETES

Christopher Brett Clark

B.S., University of Kentucky, 1991

D.M.D., University of Kentucky, 1995

A Thesis
Submitted in Partial Fulfillment of the

Requirements for the Degree of

Master of Dental Science
at the

University of Connecticut
1998

APPROVAL PAGE

Master of Dental Science Thesis

EXPRESSION AND DISTRIBUTION OF SECRETORY PROTEINS

IN THE RAT SUBMANDIBULAR GLAND
IN EXPERIMENTAL DIABETES

Presented by

Christopher Brett Clark, B.S., D.M.D.

Major Advisor
Arthur R.

Han.D.S.

Associate Advisor
Leslie S. Cutler, D.D.S., Ph.D.

Associate Advisor

No"

an Tinanoff, D.D.S., M.S.

External Advisor

Maija I. Mednieks, Ph.D.

University of Connecticut
1998

ABSTRACT

Alterations in salivary composition may contribute to the increased incidence and

severity of oral diseases in diabetes. Previous studies have shown changes in salivary

gland structure and protein expression in experimental diabetes. The present study utilized
quantitative immunocytochemistry and Westem blotting to examine the effects of diabetes
on secretory protein expression in the rat submandibular gland (SMG). Diabetes was

induced in 2-3 month old male Fischer 344 rats by streptozotocin (STZ) injection. After 30

days, tissues were collected from one group of diabetic rats, and a second group was given
insulin for 7 days. Untreated rats served as controls. Diabetic SMG acinar cells

accumulated lipid and secondary lysosomes, exhibited increased secretory granule fusion
and pooling of their contents, and had multiple laminae and folds of basal lamina.

Quantitative immunogold labeling of secretory granules in diabetic acinar cells revealed a

significant decrease (p < 0.001) in labeling density for mucin, but proline-rich proteins

(PRP) and RII, a cyclic AMP receptor protein, were minimally affected. Labeling for RII
in acinar nuclei was also minimally altered in diabetes. Insulin treatment had no significant

effect on mucin and PRP labeling, but caused a significant decrease (p < 0.001) in RII

labeling compared to control tissue. Similar changes were seen in Western blots of diabetic

SMG extracts. These results indicate that STZ-induced diabetes causes variable changes in
SMG secretory protein expression; insulin treatment alone fails to restore these proteins to
control levels. Changes in RII levels suggest that insulin and cyclic AMP pathways may
interact in regulating salivary protein expression.
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INTRODUCTION
Diabetes mellitus is a complex, multifactorial, genetically derived endocrine
disorder. It refers to an abnormality in glucose metabolism due to insulin deficiency,

impaired utilization of insulin, or an error in insulin metabolism. An elevated blood

glucose level (hyperglycemia) is the common characteristic. The disorder is evident in two
forms: type I (insulin-dependent diabetes mellitus [IDDM]) or type II (non-insulin-

dependent diabetes mellitus [NIDDM]). NIDDM, representative of impaired insulin
function and the more common form, results from defects in the insulin molecule or from

altered cellular insulin receptors. IDDM, the more severe form, is caused by the
destruction of the insulin-producing beta cells of the pancreatic islets of Langerhans. The

pathophysiology may involve an autoimmune or virally mediated destructive process.
Insulin, an anabolic hormone, promotes glucose uptake by inducing the rapid
translocation of specific glucose carrier proteins from an intracellular pool to the plasma

membrane (Espinal, 1987; Smith, 1987). Insulin plays a major role in regulating several
metabolic pathways, including fatty acid synthesis, carbohydrate metabolism and glycogen

storage, amino acid transport, and the synthesis of DNA, RNA, and protein (Smith, 1987).
The classic signs and symptoms of diabetes mellitus are more common in IDDM.

They include the triad of increased thirst (polydipsia), increased hunger (polyphagia), and

frequent urination (polyuria) together with weight loss, weakness, and fatigue. Systemic
ketosis or acidosis leading to diabetic coma or death can result from the absence of insulin

supplementation. Even with insulin supplementation some diabetic patients can develop
chronic systemic complications like retinopathy, nephropathy, sensory neuropathy, and
cardiovascular and cerebrovascular atherosclerotic diseases (Nathan, 1993).
Diabetes mellitus has also been shown to cause oral complications. Caries and

periodontal disease appear to occur with a higher frequency in untreated or poorly
controlled diabetic patients (Cutler and Valachovic, 1982; L6e and Genco, 1995).

Enlargement of the parotid gland (Russotto, 1981) has been noted, but it too seems to be
more common in poorly controlled diabetic patients (Ben-Aryeh et al., 1988,1993; Marder
et al.,

1975). Changes in salivary flow and composition (Ben-Aryeh et al., 1988, 1993;

Beeley, 1991; reviewed in Rossie, 1993) have been demonstrated. Lower resting salivary
flow rates were found in IDDM patients as compared to the NIDDM and control groups,
and the total protein concentration in whole saliva of diabetic patients was higher (Ben-

Aryeh et al., 1988, 1993). Xerostomia, or dry mouth, is another common complaint of
poorly controlled diabetics.
Insulin-dependent diabetes mellitus can be induced in rats by the administration of

streptozotocin (STZ), a broad-spectrum antibiotic extracted from Streptomyces
acromogenes. Streptozotocin has a specific cytotoxic effect on pancreatic insulin-

producing B-cells. Degranulation occurs as early as 1 hour after STZ administration and
necrosis of the B-cells is seen after 7 hours (Junod et al., 1967). Furthermore, proinsulin

biosynthesis and glucose-stimulated insulin secretion are immediately and permanently

suppressed after a brief exposure to the drug (Wilson et al., 1984). Pancreatic glucagonproducing cells, however, are not affected. Rakieten et aL (1963) were the first to report
that STZ causes diabetes in rats and dogs. During the past 35 years many studies have
confirmed this finding and found that rats treated with STZ display many of the features
seen in human subjects with uncontrolled diabetes, including hyperglycemia, polydipsia,

polyuria, and weight loss (Ar’Rajab and Ahren, 1993; Tomlinson et a/.,1992).
The effects of experimental diabetes on major salivary gland morphology have been

demonstrated. In young rats, difibetes markedly affects the growth and development of the

parotid and submandibular glands. In adult rats there is a marked increase in parotid gland
weight (Anderson, 1983) while there is a significant decrease in the submandibular gland

weight (Anderson et al., 1993, 1994). In both the rat parotid and submandibular glands,
diabetes causes rapid accumulation of lipid within the acinar cells (Anderson, 1983; Hand

and Weiss, 1984; Anderson and Garrett, 1986; Reutervig et al., 1986). The amount of

lipid in the submandibular gland, however, appears to be less and the droplets tend to be
smaller and located only in the seromucous acini and intercalated duct cells (Anderson and

Garrett, 1986; Anderson et al., 1994). In the diabetic parotid gland, acinar cells contain
crystalloid lysosomes (Hand and Weiss, 1984) and duct cells contain large vacuoles
resulting from the endocytosis of acinar secretory proteins present in the saliva (Lotti and
Hand, 1988). In the diabetic submandibular gland, Cutler et al. (1979) and Takai et al.

(1983) found pooling of secretory material and an increase in the number of autophagic
vacuoles and secondary lysosomal structures in acinar cells, and extensive cellular

degeneration and replacement of the secretory cells by fibrous connective tissue.
Anderson et al. (1993, 1994) found similar changes in some of the acinar and granular duct

cells; however, most of the cells appeared relatively normal and the glands showed no
evidence of fibrous degeneration or irreversible cellular damage. They noted the greatest

effect of STZ-induced diabetes was the significant reduction in the volume density of the

granular duct cells and the secretory granules they contain. The volume density of the
acini increased while that of the secretory granules was unaffected.

In previous studies the effects of experimental diabetes, insulin, parasympathetic
and sympathetic stimulation on the rate of protein synthesis and salivary secretion in the rat
submandibular gland were examined. Peroxidase, a secretory enzyme, and the

incorporation of 3H-leucine into trichloroacetic acid (TCA)-precipitable proteins were
decreased in alloxan diabetes and restored to control levels after insulin supplementation

(Anderson and Shapiro, 1980). This implied that insulin had a direct effect on the rate of
protein synthesis. Furthermore,it appeared that the regulation of protein synthesis
involved a bi-directional system in which alpha-adrenergic and cholinergic stimulation
inhibited amino acid incorporation, whereas beta-adrenergic agonists and insulin enhanced

the rate of synthesis (Baum et al. 1984; Anderson, 1988). Matsuura and Hand (1991),

however, found that chronic beta-adrenergic stimulation had selective effects on the

expression of several submandibular gland proteins. Namely mucin, proline-rich proteins

(PRP), and type 2 cystatin increased, glutamine/glutamic acid-rich proteins (GRP)
decreased, and protein SMG-C was minimally affected.
Anderson et al. (1993) also studied the effects of diabetes on sympathetic versus

parasympathetic nerve stimulation on the secretory response in the rat submandibular

gland. In 3 and 6 month old diabetic rats, the sympathetic flow rate was greater than
controls, but the protein concentration was reduced. The decrease in salivary protein
concentration was accompanied by a reduction in secretory granule release from acinar and

granular duct cells. No consistent differences in flow rate, protein concentration, protein
output, or secretory granule release, however, were noted following parasympathetic
stimulation in diabetic rats versus controls. Anderson et al. concluded that only the type of
nerve stimulation rather than diabetes had an effect on salivary flow rate or protein release

in the submandibular gland. Additionally, Anderson et al. (1995) found that the secretion

of proteins by the acinar cells and granular duct cells of the submandibular gland varies

according to the degree and type of neural stimulation sympathetic versus

parasympathetic. From these studies, it seems that sympathetic (beta-adrenergic) responses
are more affected in diabetes than parasympathetic responses.

Several studies of experimental diabetes have demonstrated changes in salivary

protein composition in the major salivary glands. In the parotid gland, amylase (Anderson
and Johnson, 1981; Anderson, 1983, 1987; Kim et al., 1990; Zebrowski and Brimmer,

1978) and amylase mRNA levels (Kim et al., 1990) decreased in diabetic rats and were
restored with insulin treatment. Other secretory proteins, such as parotid secretory protein

(PSP) (Lotti and Hand, 1988; Sczepanski et al., 1998) and PRP (Anderson and Johnson,
1981; Anderson, 1991; Szczepanski et al., 1998), showed a significant decrease in diabetic
rats while insulin reconstimtion had little or no effect. In the submandibular gland, Chan et

al. (1993) showed that all activities of the proteinases, tissue kallikrein and tonin, were

significantly reduced in diabetic rats. Insulin treatment restored tissue kallikrein activity,
whereas the activity of tonin was unchanged.

The effects of experimental diabetes on the expression and distribution of the

secretory proteins in the rat submandibular gland have not been studied. The proteins that
will be examined can be divided into two groups: adult acinar cell secretory and cellular

regulatory proteins. The majority of proteins produced in the rat submandibular gland
originate from the adult acinar cells. Therefore, proteins such as SMG mucin and PRP
will be evaluated. A cyclic AMP receptor protein (cARP) will be studied to determine if

cyclic AMP-mediated reactions are involved in regulating salivary protein expression in
diabetes. Specifically, the type II regulatory subunits (RII) of cyclic AMP-dependent

protein kinase (protein kinase A [PKA] ) will be examined. The cARP are critical

components of the major intracellular pathway regulating secretion and gene expression in
salivary glands (Flockhart and Corbin, 1982; Lohmann and Walter, 1984; Krebs, 1992).
These proteins have been found in secretory granules (Mednieks et al., 1987) and are
secreted in rat saliva (Mednieks and Hand, 1984) and human saliva (Mednieks et al.,

1993). Type II R subunits have specific cellular functions as protein and DNA binding
proteins. Additionally, RII has been shown to bind to actin and may be involved in the

cytoskeletal activity of secretory cells (Scott et al., 1990). The specific function of cARP in
saliva, however, is not presently known.

Although some proteins of rat submandibular saliva like GRP have no direct
counterpart in human saliva, others, such as mucin glycoprotein, PRP, and RII share many
similarities with their human analogs. These proteins have many functions that probably
are important for oral health in both species. If diabetes alters the synthesis and expression

of these proteins, an individual’ oral health could be compromised.
The fundamental hypothesis, therefore, is that the synthesis and cellular distribution

of secretory proteins are altered as a consequence of diabetes, and are measurable as

changes in the expression of specific proteins in the submandibular gland.

OBJECTIVES
1. General Goal:

To determine the effects of experimental diabetes on the expression and cellular
distribution of secretory proteins in the submandibular gland of control, diabetic, and
insulin-treated diabetic rats.

2. Specific Objectives:

A.) Compare the morphology of the rat submandibular gland in control,
diabetic, and insulin-treated diabetic groups.

B.) Compare the expression and distribution of secretory proteins (mucin, PRP,
and RII) in the rat submandibular gland of control, diabetic, and insulin-treated diabetic

groups using quantitative electron microscopic immunocytochemistry.
C.) Identify and characterize the expression of these secretory proteins in tissue
extracts of the rat submandibular gland of control, diabetic, and insulin-treated diabetic

groups using SDS-polyacrylamide gel electrophoresis (PAGE) and Western blotting.

3. Experimental Design

A.) The rat has served as an animal model in numerous studies. The experimental
system employed in this study was salivary gland tissues of streptozotocin-treated rats.

Many features of this system are similar to those seen in human subjects with uncontrolled
diabetes mellitus (Ar’Rajab and Ahren, 1993; Tomlinson, 1992). The morphology of the

salivary glands and the location and functions of their proteins are well documented.

B.) Both quantitative electron microscopic immunocytochemistry and Western
blotting were used for comparison of the expression of secretory proteins. In

immunocytochemistry the detection of a whole protein versus its proteolytic fragments
cannot be easily distinguished, while in PAGE and Western blotting it can. Therefore, this

approach can help determine whether changes seen in the expression of secretory proteins
are due to effects on synthesis or degradation.

MATERIALS AND METHODS
Animals and Animal Care

Two to three-month old, viral antibody-free, male NIA-Fischer 344 rats were
purchased from Harlan Sprague Dawley (Indianapolis, IN). The housing, care, and use of
the animals were in accordance with NIH guidelines, and all procedures involving animals
were reviewed and approved by the University of Connecticut Health Center Animal

Care Committee. The rats were housed in plastic microisolator cages and randomly
assigned to control, diabetic, and insulin reconstitution groups. They were fed autoclaved
rat chow and water ad libitum and allowed to acclimate for 3-5 days prior
to inducing diabetes. The experimental animal work involving the induction of diabetes,

the subsequent administration of insulin, and the tissue collection and preparation was

previously performed by Szczepanski et al. (1998). Tissues from the control animals were
collected and processed specifically for this study.

Induction and Assessment

of

Diabetes

Diabetes was induced by intraperitoneal injection of 35-40 mg/kg streptozotocin

(STZ, Sigma Chem. Co., St. Louis, MO) in 0.01 M citrate buffer, pH 4.5. The rats were
observed daily, and the development and course of the diabetes were followed by weighing
the rats weekly and monitoring blood glucose with the One-Touch II glucose
meter (Lifescan, Milpitas, CA), using a drop of blood from the lateral tail vein. Diabetic

animals failed to gain, or lost weight, exhibited polyuria and polydipsia within a few

days, and had blood glucose levels routinely exceeding 400 mg/dL. Beginning at one
month after the induction of diabetes, one group of animals was treated with Lente insulin

(10 Units/day, s.c.) daily for 7 days. Blood glucose levels of insulin-treated animals were
monitored periodically to evaluate the insulin replacement therapy.

Serum Glucose Measurements
Blood samples were drawn from the hearts of anesthetized rats, prior to killing.

Serum was separated from clotted blood samples and stored at-70 C. Serum glucose
levels were determined by the hexokinase method, using an assay kit and procedures from

Sigma Chemical Co. (St. Louis, MO).

Tissue Preparation

for

Electron Microscopy

Submandibular glands were fixed by vascular perfusion of anesthetized rats

(sodium pentobarbital, 50 mg/kg body weight, i.p.) with 1% glutaraldehyde in 0.1 M
sodium cacodylate buffer, pH 7.4, then excised and immersed in fresh fixative solution.

After fixation for 1 hour, the glands were rinsed and stored briefly at 4 C in 0.1 M

cacodylate buffer, pH. 7.4. Small submandibular gland tissue pieces about 1 mm were

randomly selected, dehydrated in ethanol, and substituted with propylene oxide. Multiple
sectioning blocks were prepared by embedding in PolyBed (Polysciences, Warfington,

PA) and polymerizing at 60 C. For morphological study, some tissue was postfixed in
1% osmium tetroxide and stained with 0.5% aqueous uranyl acetate prior to embedding in

PolyBed.
Several PolyBed blocks were randomly selected. One gm thick sections were cut
with glass knives, stained with methylene blue-Azure II, and examined in the light

microscope for orientation. Tiss.ue blocks containing the selected areas were sectioned to
a thickness of 70-90 nm using a diamond knife, and the sections were collected on 300

mesh copper grids for morphological study. Another series of sections was collected on
uncoated nickel grids for immunogold labeling.
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Morphological Analysis
Acinar cells of control, diabetic, and diabetic insulin-treated animals were examined

using a JEOL 100 CX transmission electron microscope (TEM) at low magnification

(1,600 to 2,600X) for morphological features. Morphological characteristics and changes
were then examined at higher magnifications, photographed, and printed at final

magnifications ranging from 4,700X to 47,000X.

Antibodies

For the adult acinar cell proteins, anti-SMG mucin (mouse monoclonal antibody)
was obtained from Dr. L. Tabak, University of Rochester (Moreira et al., 1989), and anti-

PRP (rabbit antibody) was a gift from Dr. D. Carlson, University of Califomia, Davis
(Ziemer et al., 1982). An antibody to the cellular regulatory protein, RII (rabbit antibody),
was prepared by Dr. M.I. Mednieks, University of Illinois-Chicago/University of

Connecticut Health Center.

Immunogold Labeling

Immunogold labeling was performed as described by Hand (1995). For mucin and

PRP, one grid from each animal was randomly selected for each antibody and treated with
1% BSA (bovine serum albumin)-1% instant milk in phosphate-buffered saline (PBS) for
30 minutes at room temperature to block non-specific binding of antibodies. The grids
were transferred to primary antibody diluted in 1% BSA with 5% normal goat serum

(NGS) in PBS for overnight incubation at 4C. For RII, one grid from each animal was
randomly selected and treated with 2X Teloblot (4% w/v non-mammalian proteins, 1 gM
sodium azide, 0.01% Tween-20 detergent) for 30 minutes at room temperature, and

transferred to primary antibody diluted in 2X Teloblot for overnight incubation at 4C. The

bound immunoglobulins were visualized by incubation for 60 minutes at room temperature
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with 10 nm gold labeled goat anti-rabbit IgG or goat anti-mouse IgG (Amersham,

Arlington Heights, IL). After rinsing with PBS and distilled water, the sections were
stained with uranyl acetate and lead citrate and examined in a JEOL 100 CX TEM.

Immunocytochemical controls included substitution of preimmune or non-immune sera or
1% BSA-5% NGS for the primary antibody.

Quantitation

of Immunogold

Labeling

Cells were randomly selected on the microscope screen at low magnification

(5,000X) so that gold particles were not visible, then photographed at approximately
16,000X, and printed at a final magnification of 43,000X. For mucin and PRP in each
animal, ten fields containing secretory granules and three fields containing nuclei were

photographed. For RII, ten fields of each organelle were photographed. Quantitative
analyses of the immunogold labeling of intracellular compartments were done on the prints
using a digitizing tablet and SigmaScan software (Jandel, Corte Madera, CA). Non-

specific binding was evaluated over areas of plastic (2 per grid) adjacent to tissue. Analysis
of variance (ANOVA), using the Statistical Program for Social Scientists (SPSS) software,
was applied to determine if differences among mean labeling densities of control, diabetic,

and insulin-reconstituted samples were statistically significant. Specific differences
between the sample means were tested for statistical significance using Bonferroni and

Tukey post-hoc tests.

Tissue Preparation

for

Gel Electrophoresis and Western Blotting

The rats were euthanized with CO2 and killed by cardiac transsection. Glands were

then dissected, trimmed of extraneous tissue, cut in 0.5 cm3 pieces, frozen in liquid

nitrogen, and stored at -70 C. Prior to assay, the randomly selected tissue samples were
thawed in distilled water and an equal volume of 0.1 M Tris buffer, pH 6.8, containing

0.15 M KC1 and 1

ktM each of phenylmethylsulfonyl fluoride and benzamidine.

The
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tissues were homogenized with a Polytron probe, transferred to micro-centrifuge tubes,

and centrifuged at 10 kG. Supematants containing soluble cell components were recovered
and diluted to appropriate protein concentrations (approximately 0.5 mg/ml total protein) in

sample buffer (0.1% bromphenol blue, 10% SDS, distilled water, glycerol,

mercaptoethanol), heated to 90 C, and stored at-70 C.

SDS-Polyacrylamide Gel Electrophoresis and Western Blotting
The samples for gel electrophoresis were placed in a boiling water bath for 5
minutes and cooled to room temperature. They were applied to 12% sodium dodecyl

sulfate (SDS)-polyacrylamide gels to separate the proteins according to molecular size

(Laemmli, 1970). A Rainbow marker vr (Amersham RPN 756, Arlington Heights, IL)
with molecular weights ranging from 14.3 to 220 kD was used as the standard. The gels
were run at 50 volts for 2.5 to 3 hours in the presence of 10.8 M ethylenediaminetetraacetic

acid (EDTA) for calcium chelation to prevent streaking of the submandibular gland extract

that probably occurred as a result of mucin complexes. Banding patterns of parotid gland
extract were more distinct and had minimal streaking even if they were mn at higher

voltages and for shorter times. The proteins were transferred to nitrocellulose membranes
by electroblotting (Towbin et al., 1979). The nitrocellulose membrane was stained with
0.5% Ponceau S dye in 5.0% trichloroacetic acid to ensure that efficient protein transfer
had occurred and to help determine total protein loaded for each lane. For immunoblotting,
the membrane was washed with PBS and distilled water for 30 minutes to remove the

Ponceau S. The membrane was incubated in 5X Teloblot or 1% BSA-1% instant milk for
1 hour to block non-specific binding sites.
Detection of the proteins on the membrane was achieved by an indirect method.

The membrane was incubated in a solution of unlabeled primary antibody and PBS-

(0.5X)Teloblot or PBS-1% BSA at room temperature for 1 hour and then at 4 C
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overnight. The primary antibodies (anti-mucin, anti-PRP, anti-RII) used for immunogold
labeling were also employed for Western blotting. The membrane was washed with 3

changes of PBS to remove unbound primary antibody. A secondary antibody labeled with
horseradish peroxidase in a dilution of PBS-(0.5X)Teloblot or PBS-1% BSA was added,

and the membrane was incubated for 1 hour at room temperature. The secondary
antibodies utilized were goat anti-mouse polyvalent immunoglobulins and goat anti-rabbit

IgG conjugated to horseradish peroxidase (Sigma, St. Louis, MO). The membrane was
washed with 3 changes of PBS. Diaminobenzidine (DAB) 6 mg, 10 ml 50 mM Tris, pH

7.6, and 15 l.tl 30 % hydrogen peroxide were added to the membrane and incubated at
room temperature for 1-5 minutes. A brown reaction product identified the specific protein

band on the membrane.

A Ponceau S record of total protein loaded for each lane and immunoblots of each
protein (mucin, PRP, RII) were scanned using OFOTO software, and band density
measurements were done using NIH Image software. The integrated density, area under
the curve, and background measurements in the densitometric scans were tabulated for

quantitation of the total protein and each specific protein (not shown). The expression of
the specific proteins was calculated from these tables and is shown as ratio of each specific

protein measured by Western blotting to the total protein applied to the PAGE lane

(Tables 4,5).

RESULTS
Serum Glucose and Body Weight
Polydipsia, polyphagia, and polyuria were seen in all diabetic rats. Mean serum

glucose levels in animals one month after the induction of diabetes increased over 3.5 fold
compared to control animals (Table 1), while mean body weights of diabetic rats decreased
21.5% from initial weights. After insulin treatment for 7 days, mean serum glucose levels
were elevated only 2.5 fold compared to control animals. Insulin treatment also resulted in
a mean increase of 7.40% from the animals’ diabetic weight.

Morphology
The morphological features of the submandibular glands of control animals were
similar to those described in previous studies (Anderson et al., 1993,1994; Cutler et

a/.,1979; Takai et a/.,1983). The seromucous acinar cells contained electron lucent

secretory granules of varying size with a finely filamentous content in the apical two-thirds
of their cytoplasm (Fig. 1 a,b). Some secretory granules were occasionally fused with one
another. Nuclei, endoplasmic reticulum, and Golgi apparatus were positioned in the basal
one-third of the cell.

One month after the induction of diabetes, the acinar cells displayed several
abnormalities. Lipid accumulation in the basal cytoplasm was the most common

observation, while folding of the basal lamina and multiple laminae were also prominent

(Fig. 2a, b). In addition, the presence of secondary lysosomes and the coalescence of
secretory granules and pooling of their contents were noted (Fig. 2c,d). The acinar cells of
insulin-treated diabetic animals showed no lipid accumulation and had relatively normal

morphological features (Fig. 3a,b).
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Quantitative Immunocytochemistry

Immunogold labeling of rat submandibular gland acinar secretory granules with
anti-mucin antibody was significantly reduced (p < 0.001) in diabetes. No effect on the

labeling density was seen with insulin treatment (Fig. 4a,b,c; Table 2). Labeling of
secretory granules with antibody to PRP was reduced in the diabetic and insulin-treated
diabetic tissues, but the differences were not statistically significant (Fig. 5a,b,c; Table 2).

Immunogold labeling of acinar secretory granules and nuclei with anti-RII antibody was
unaffected in diabetes. A significant decrease (p < 0.001) in the labeling density of

granules and nuclei occurred in the insulin-treated diabetic tissue (Fig. 6a,b,c; Fig. 7a,b,c;
Table 3). Background labeling density was low (0.25-0.86 gold particles/tmz) and did not
differ among the three groups for mucin and PRP antibodies. The background labeling

density for RII antibody in the insulin-treated diabetic tissue (8.46 gold particles/m) was
significantly increased (p < 0.01) compared to the control tissue (4.66 gold particles/tm).

SDS-Polyacrylamide Gel Electrophoresis and Western Blotting
Submandibular gland tissue extracts were analyzed using Western blots of proteins

separated by SDS-PAGE and electroblotted onto nitrocellulose membranes. Antibodies
against SMG-mucin, PRP, and RII recognized bands of approximately 114, 25-35, and 50
kD, respectively (Fig. 8,9,10). Densitometric analysis of Western blots showed a decrease
in the integrated densities of mucin, PRP, and RII for the diabetic rats and a virtual remm
to control levels for the insulin-treated diabetic groups (Fig. 11,12,13).

The integrated density, area under the curve, and corrections for background in
scans of each specific protein immunoblot and the total protein record were used to

quantitate the expression of each protein. Diabetic rats had a significant decrease in the
expression of mucin, while PRP and RII were minimally reduced (Table 4). Insulin
treatment partially restored the concentration of mucin to control levels, returned PRP fully
to control levels, and increased RII above control levels.
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Electrophoretic separation and Western blotting were also used to analyze parotid

gland tissue extracts (Fig. 8,9,10). The expression of PRP and RII were decreased in the
diabetic rats (Table 5). In the insulin-treated diabetic group, PRP expression was almost

restored to control levels, while RII levels displayed a further decrease. As expected,
mucin was not found in parotid extracts. Densitometric scans showing integrated densities

for PRP and RII in control, diabetic, and insulin-treated diabetic groups (Fig. 14,15)
exhibited changes similar to their calculations for protein expression (Table 5).

DISCUSSION
The classic triad signs of insulin-dependent diabetes mellitus (polydipsia,

polyphagia, and polyuria) were seen in all diabetic rats. Similar to the results reported in
other studies (Anderson and Shapiro, 1979; Anderson et aL, 1993,1994; High et al.,

1985), a reduction in body weight and an increase in mean serum glucose levels in diabetic
animals were also noted. After insulin treatment for 7 days, body weight increased and

mean serum glucose levels decreased compared to the animals’ diabetic measurements.

The rat model of IDDM in our study, therefore, has the major manifestations seen in human
diabetes.

The submandibular gland of diabetic rats exhibited morphological changes similar
to those described in previous studies. Lipid droplets in the basal cytoplasm were evident

in many seromucous acinar cells. Additionally, pooling of secretory material and the

presence of secondary lysosomes were observed, but autophagic vacuoles or extensive
cellular degeneration as noted by Cutler et al. (1979) and Takai et al. (1983) were not seen
in the electron microscopic fields examined. These differences may be due to varying

experimental conditions between our study and theirs that include the strains of rats
(Fischer vs. Sprague-Dawley) and the time at which the diabetic tissues were observed (30

days vs. 4 hrs. to 21 days). Also, examining larger areas with light microscopy could have
revealed the presence of necrotic secretory cells and connective tissue replacement. Our

observations, however, were similar to those of Anderson et al. (1993,1994) except we
noted that most of the acinar cells present in the diabetic gland showed at least a few
characteristic morphological changes.

In addition, extra basal lamina material deposited around the acinar cells was
observed in our study. Previous studies of the diabetic rat submandibular gland have not

reported the presence of excessive basal lamina material. These findings resembled

changes seen by Hand and Weiss (1984) and Szczepanski et al. (1998) in the diabetic rat
parotid gland. Basal lamina alterations have also been found in human diabetic studies
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involving the kidney (Huang, 1980) and muscle (Kilo et al., 1972). At present it is not
known whether the salivary gland changes in human diabetes include basement membrane
alterations. A study by Rohrbach et al. (1982) found that the synthesis and quantity of

basement membrane components such as Type IV collagen and laminin are increased in
diabetes, while the synthesis and sulfation of basement membrane proteoglycans are

reduced. Studies by Kanwar and Farquhar (1979) and Kanwar et al. (1980) suggest that
the highly anionic proteoglycans account for the permeability and filtration properties of the
basement membrane. It has been hypothesized that cells compensate for the defective
nature of the basement membrane in diabetes by enhancing synthesis that results in the

increased thickness and layering (Rohrbach et al., 1982). As in the kidney, the salivary

gland epithelium constitutes a major site of fluid and electrolyte transfer (Schneyer et al.,

1972). Therefore, the basement membrane alterations seen in STZ- induced diabetes could
cause changes in salivary flow and composition which could influence the function of the

submandibular gland.

The morphology of the diabetic rat submandibular gland after insulin treatment has

rarely been documented. In our study we observed that the seromucous acinar cells, after
only 7 days of insulin treatment, had no lipid accumulation or other morphological features
that were characteristic in the diabetic rat. This supports the observations of Morris et al.

(1992) who found that the lipid content and the fatty acid profiles of all major salivary
glands return to normal after 7 days of insulin treatment.
Quantitative immunocytochemistry has been used to assess the effects of various

experimental conditions on the expression and distribution of secretory proteins in several
tissues, including the parotid gland (Lotti and Hand, 1988; Szczepanski et al., 1998) and

pancreas (Gr6goire and Bendayan, 1986,1987) in experimental diabetes. This is the first
study, however, to apply this methodology to the rat submandibular gland in experimental
diabetes. Previous studies have used submandibular gland homogenates and chemical

assays to analyze the activities of secretory enzymes. Anderson and Shapiro (1980) found
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that peroxidase activity was reduced in alloxan diabetes and restored to control levels after
insulin treatment. Chan et al. (1993) noted that all activities of the proteinases, tissue

kallikrein and tonin, were significantly decreased in STZ-diabetic rats, while insulin
treatment restored tissue kallikrein activity and had no effect on tonin activity.

Immunogold labeling of submandibular gland sections with antibodies to individual
secretory proteins revealed specific responses of the seromucous acinar cells to diabetes.
Mucin was the only secretory protein to have a significant decrease (p < 0.001) in granule

labeling density. RII granule labeling density was not affected in diabetes, while an
insignificant decrease was seen in PRP labeling. Our study has revealed that the

expression of individual submandibular secretory proteins are variably affected in diabetes.
Szczepanski et al. (1998) observed similar variability in the effect of diabetes on the
expression of secretory proteins in the parotid gland. They found that the granule labeling

density of amylase, PRP, and parotid secretory protein (PSP) are significantly decreased,
while the labeling density of RII and acidic epididymal glycoprotein (AEG) were minimally

affected.
The presence of mature and active proteins in a cell is the sum of the complex steps
in gene expression: 1) synthesis of the primary transcript; 2) turnover and processing of

the primary transcript; 3) transport of the mRNA out of the nucleus and turnover in the

cytoplasm; 4) translation; and 5) modification and protein turnover. Therefore, factors at

any of these steps may control the abundance of the mRNAs and play an important role in
the regulation of protein levels (Kousvelari and Tabak, 1991).
The regulation of protein levels by insulin involves both the transcription and
translation processes. First, insulin must bind to the extracellular domain of an insulin

receptor within the plasma membrane of a target cell. The receptor activates an intracellular

tyrosine protein kinase that phosphorylates a number of intracelluar proteins (substrates).
Insulin receptor substrate (IRS)-1 activates phosphatidylinositol 3-kinase which in turn
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activates several signaling pathways which stimulate the transcription of certain genes and

regulates the translational process of protein synthesis (Moule and Denton, 1997).

In our study, insulin treatment had no significant effect on the restoration of mucin,
PRP, or RII granule labeling densities to their control levels. In fact, a significant decrease
(p < 0.001) was seen in the granule labeling density of RII for insulin-treated diabetic
animals compared to control animals. Variability is observed in how insulin treatment

affects the expression of each specific secretory protein. Chan et al. (1993) and

Szczepanski et al. (1998) made similar observations in their studies. Szczepanski et al.

(1998) found that in the parotid gland insulin treatment had no effect on PRP, PSP, or
AEG levels, while a significant decrease occurred in RII granule labeling.
One reason why insulin alone did not restore the secretory proteins to their control
levels is that other hormones or biological factors could be involved in the expression of
these proteins. Many genes in other tissues such as pancreatic amylase, pituitary growth

hormone, and liver pymvate kinase are regulated by insulin in conjunction with cyclic

AMP, glucocorticoids, thyroid hormones, and/or androgens. The effect of cyclic AMP on
these genes is often opposite of the insulin effect. Under normal physiological conditions,
these regulators coexist and interact to influence transcription (Meisler and Howard, 1989).
Considerable evidence suggests that in rodents the biosynthesis, processing, and
secretion of salivary secretory proteins are also mediated by the sympathetic nervous

system. I-adrenoreceptor stimulation has a profound effect on the regulation of mRNA
levels of many salivary gland genes like amylase, PRP, PSP, and tissue kallikrein. The

mRNA for most of these genes are regulated by cyclic AMP (Kousvelari and Tabak,
1991). Typical examples of genes for which transcription is regulated by cyclic AMP or
agents that increase cyclic AMP include the liver enzyme phosphoenolpymvate
carboxykinase (Sasaki et al., 1984) and the hypothalamic peptide somatostatin (Gonzalez
and Montminy, 1989). It has been found that cyclic AMP mediates the hormonal induction
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of these genes by a conserved cyclic AMP response element (CRE) present in their

promoter region (Montminy, 1987).
Another reason for the failure of insulin to restore the secretory proteins to control
levels could be due to the protocol used for the administration of insulin to the diabetic rats.

They were given single daily insulin injections which probably resulted in widely varying
serum insulin levels throughout the day. Since mean serum glucose levels of our insulin-

treated diabetic rats didn’t return fully to control levels after 7 days of treatment, it could be

expected that protein levels might not return to control levels either.
Previous studies have revealed that the expression of secretory proteins which are

common to different tissues can be variably affected in diabetes. The labeling density of

secretory granules for amylase is reduced by about 50% in the diabetic parotid gland
(Szczepanski et al., 1998), whereas it is virtually abolished in the pancreas (Gr6goire and

Bendayan, 1986,1987; Szczepanski et al., 1998). For secretory enzymes, Anderson and
Shapiro (1980) found that peroxidase activity decreased in the diabetic submandiublar

gland, while it increased 54% in the parotid gland (Anderson et al., 1983). In this study,
we observed that the granule labeling density of PRP in the submandibular gland is

minimally reduced in diabetes, while Szczepanski et al. (1998) noted a significant decrease
in the parotid gland. Our studies, however, noted that the granule labeling density of RII
was minimally affected in diabetes in both glands. Insulin treatment had no effect on the

restoration of PRP and RII to control levels in either gland. The fact that insulin did not
restore the proteins to control levels suggests that other hormonal factors are also involved

in regulating the PRP and RII genes. The differences in PRP expression between the

submandibular and parotid gland in diabetes indicate that the effects of diabetes on
submandibular PRP gene expression is relatively weak compared to the parotid gland. The
differences could also indicate that the regulation of the PRP gene in each gland is tissue

specific, and that different hormones are involved in its expression in the two salivary

glands.
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The RII protein is present not only in salivary gland acinar secretory granules

(Mednieks et al., 1987; Szczepanski et al., 1998), but it is predominantly an ubiquitous
cellular constituent that is evident in the acinar nuclei and cytoplasm and in other rat tissues
such as the heart and brain (Szczepanski et al., 1998). Szczepanski et al. observed a

significant decrease in RII labeling of the acinar nuclei in the diabetic parotid gland, while
insulin treatment partially reversed the changes. In our study RII nuclear labeling was

minimally affected in the diabetic submandibular gland, and significantly decreased in
insulin-treated diabetic tissues compared to control tissues. This follows the same pattern
we observed in RII labeling density of secretory granules.

Western blotting of the secretory proteins was used in our study for comparison to
the quantitative immunocytochemistry results and to determine if whole proteins or their

proteolytic fragments were detected by the antibodies. Although no statistical analysis was

performed, similar patterns of secretory protein expression in Western blotting were seen
compared to immunogold labeling. The protein concentration of mucin had a large
decrease in the diabetic submandibular gland, while PRP and RII levels were minimally

reduced. Subsequent insulin treatment, however, had a different effect on each protein. It

restored the concentration of each protein to varying degrees compared to control levels.
This contrasts with the results obtained with immunogold labeling, where no significant

effect of insulin treatment on the restoration of the secretory proteins was observed.

Immunogold labeling and Western blotting measure protein expression in different

ways which could account for discrepancies seen in the results for the insulin-treated
diabetic tissues. In immunogoldlabeling, the proteins can be localized and quantitated in

specific cellular compartments such as secretory granules. Western blotting, on the other
hand, utilizes extracts of homogenized salivary gland tissue which contain proteins from all

cellular compartments including secretory granules, endoplasmic reticulum, Golgi

apparatus, and ductal lumina. Also, different epitopes are available on the PolyBed plastic

compared to the nitrocellulose membranes that could affect binding of the primary
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antibodies. Another factor to be considered is that the expression of the secretory proteins
in the submandibular gland is small compared to the parotid gland which could affect their

quantitation in Westem blotting.

Westem blotting of parotid secretory proteins was performed to confirm the results
seen for the submandibular secretory proteins. The significant decrease seen in diabetic

parotid PRP concentrations in Western blotting has been observed in previous studies.
Based on changes in electrophoretic banding patterns, Anderson and Johnson (1981) and
Anderson et al. (1991,1993) also found that diabetes decreases parotid PRP levels. The
effect of insulin on PRP levels, however, was not examined in their study. We observed a

partial restoration of PRP to control levels with insulin treatment.
The Westem blotting results indicate that the major electrophoretic pattems of the
three secretory proteins, mucin, PRP, and RII, were consistent with their established
molecular weights. This indicates that large whole proteins rather than their proteolytic

fragments were detected. Thus, changes seen in the expression of secretory proteins in
diabetes are most likely due to effects on synthesis rather than degradation.

Mucin, PRP, and RII of the rat submandibular gland share many similarities with
their human analogs. These proteins have many functions that probably are important for

oral health in both species. Mucin contributes to the formation of a thin salivary film which
covers all intraoral surfaces. This coating is thought to hydrate and lubricate the soft
tissues of the mouth and contribute to the formation of the acquired enamel pellicle, which

may serve as a permeability barrier and help protect the underlying hard tissue from
demineralization by acids formed by tooth-borne flora. Mucin, along with other factors in

saliva, helps modulate both the number and type of microorganisms that colonize the mouth

by favoring attachment and subsequent proliferation of certain organisms while promoting
the clearance of others (Tabak, 1995). The significant decrease seen in the expression of
mucin in diabetes and the lack of its restoration with insulin treatment may have important

implications for an individual’s oral health.
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The largest protein family in human salivary secretions, PRP, are proposed to be
involved in calcium binding, hydroxyapatite binding, formation of the acquired enamel

pellicle, and agglutination of oral bacteria (Carlson, 1988). Since PRP and mucin share

many similar functions, the relatively normal expression of PRP in diabetes may offset
some of the detrimental effects on oral health normally associated with the disease.

The cyclic AMP receptor protein (cARP), RII, is present in the secretory granules,
nuclei, and cytoplasm of salivary gland acinar cells. While the precise role of RII as a

secretory protein is unknown, it is a critical component of the major intracellular pathway
regulating secretion (Quissell et al., 1988, 1993) and gene expression (Flockhart and
Corbin, 1982; Lohmann and Walter, 1984; Krebs, 1992; Lin et al., 1993; Ann et al., 1997)
in salivary glands. Although the effects of diabetes and insulin on RII expression have not

been previously determined, other components of the cyclic AMP system are known to be
altered. Cyclic AMP phosphodiesterase activity is decreased in experimental diabetes

(Solomon, 1975; Solomon et al., 1989), and insulin inhibits the activities of adenylate
cyclase (Illiano and Cuatrecasas, 1972) and PKA (Walkenbach et al., 1978). The
expression of the secretory proteins, mucin (Kousvelari and Tabak,1991) and PRP

(Carlson et al., 1991; Lin et al., 1993; Ann et a/.,1997), are known to be regulated by
cyclic AMP. Thus, changes in the activity and/or expression of specific components of the
cyclic AMP signaling system, such as RII, during diabetes and subsequent insulin
treatment may influence submandibular gland function.

The regulation of gene expression for the submandibular gland secretory proteins
involves a complex interrelationship among insulin, the sympathetic nervous system, and

possibly other hormones that is not fully understood. Beta-adrenergic regulation (cyclic
AMP-mediated) of gene expression, specifically transcription, in the parotid and
submandibular gland has been partially elucidated. Future studies should concentrate on

how insulin, through its signaling pathways, regulates gene expression in the normal
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physiologic and disease states of the salivary glands. Additionally, the complex
interactions between insulin and cyclic AMP should be addressed.

Tables
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Table 1. The effects of experimental diabetes and insulin treatment
on serum glucose levels and body weight.

Group

Serum Glucose (g/dL)

Control

134 + 17.3 (4)*

Diabetic

483 + 23.7 (3)

Insulin

339 + 35.5 (4)

Body Weight Change (%)

-21.5

2.28 (7) a

+ 7.40 + 1.08 (4) b

* Mean value + standard error (number of animals).
a

Reduction in weight from control to diabetic state (number of animals).

b

Increase in weight from diabetic to insulin-treated state (number of animals).
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Table 2. Morphometric analysis of immunogold labeling of
submandibular gland acinar secretory granules for mucin

and PRP (gold particles/tm).

Group
Control

Mucin

15.2 _+ 1.00 (29) a

PRP
31.8 _+ 3.42 (30)

Diabetic

8.85 + 0.83 (10)*

23.0 + 1.75 (10)

Insulin-treated

7.03 + 0.44 (48)*

26.6 +_ 1.42 (50)

a

Mean value + standard error (number of fields).

* Statistically different from control (p < 0.001).

29

Table 3. Morphometric analysis of immunogold labeling of submandibular

gland acinar secretory granules and nuclei for RII (gold

particles/gm).
Group

Secretory Granules

Control

10.3 + 0.66 (30) a

17.2 + 1.19 (30)

Diabetic

8.32 + 0.44 (10)

13.3 + 0.40 (10)

Insulin -treated

6.80 + 0.25 (50)*

11.9 + 0.56 (50)*

a

Mean value + standard error (number of fields).

* Statistically different from control (p < 0.001).

Nuclei
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Table 4. The effects of experimental diabetes and insulin treatment
on submandibular gland protein expression measured

from Western blots.

Group

Mucin

PRP

RII

Control

.105

.031

.052

Di abetic

.076

.024

.048

Insulin-treated

.093

.030

.068

The expression of the specific proteins (mucin, PRP, and RII) are shown as a
ratio of the specific protein measured by Western blotting to the total proteins
applied to the PAGE lane. The values are averages of two experiments.
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Table 5. The effects of experimental diabetes and insulin treatment
on parotid gland protein expression measured from

Western blots.

Group

PRP

RII

Control

.130

.293

Diabetic

.078

.224

Insulin-treated

.120

.201

The expression of the specific proteins (PRP and RII) are shown as a ratio

of the specific protein measured by Westem blotting to the total proteins

applied to the PAGE lane. Mucin is not found in parotid extract.
Values are from experiment 1. Values for experiment 2 (not shown) were lower
due to total protein loaded, but they had the same relationships between groups.

Figures
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Key to Abbreviations
B

Basal lamina

ER

Rough endoplasmic reticulum

G

Golgi apparatus

IC

Intercellular canaliculi

L

Lumen

LD

Lipid

LY

Lysosome

M

Mitochondrion

MC

Myoepithelial cell process

N

Nucleus

SMG

Submandibular gland

SG

Secretory granules

Figure Legends
Figure 1. Electron micrographs of control rat submandibular gland.

(A.) Several seromucous acinar cells surround the lumen. The cells are
similar in size and contain many electron-lucent secretory granules (x 5,900;

scale bar= 2 gm).

(B.) High magnification of an acinar cell exhibiting secretory granules, rough
endoplasmic reticulum, and a mitochondfion. Note the fine filamentous nature
of the granule conteiat (x 47,000; scale bar= 0.5 gm).

Figure 2. Electron micrographs of diabetic rat submandibular gland.

(A.) Portion of a submandibular gland showing 3 seromucous acinar cells.
Several intercellular canaliculi are seen. Note the lipid accumulation in the
basal cytoplasm and the lysosomal body (x 9,000; scale bar= 1 gm).
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(B.) High magnifcation showing deposition of extra basal lamina material,
including folds and multiple laminae. Rough endoplasmic reticulum and
mitochondria are present in the acinar cells (x 22,000; scale ba- 1 tm).

(C.) High magnification displaying coalescence of secretory granules and
pooling of their contents (*). Mitochondria and Golgi apparatus are also
shown (x 22,000; scale bar= 1 tm).

(D.) High magnification showing a lysosome. Mitochondria and Golgi
apparatus are also present (x 22,000; scale bar= 1 tm).

Figure 3. Electron micrographs of insulin-treated diabetic rat
submandibular gland.

(A.) Portion of a submandibular gland showing 5 seromucous acinar cells.
Several intercellular canaliculi are present. Note the relatively normal

morphological features and the absence of lipid accumulation (x 4,700; scale
bar= 2 ].tm).

(B.) High magnification of an intercellular area between acinar cells exhibiting
a myoepitheial cell process. Secretory granules, rough endoplasmic

reticulum, and mitochondria are also shown (x 29,000; scale bar= 1 tm).

Figure 4. Immunogold labeling of acinar secretory granules with anti-SMG
mucin antibody.

(A.) Control, (B.) diabetic, (C.) insulin-treated diabetic rat. Note the
decreased reactivity of granules in the diabetic and insulin-treated diabetic
tissues. Granule content appears aggregated due to the omission of osmium
tetroxide for fixation in immunogold studies (x 43,000; scale bar= 0.5

tm).
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Figure 5. Immunogold labeling of acinar secretory granules with anti-PRP
antibody.

(A.) Control, (B.) diabetic, (C.) insulin-treated diabetic rat. Fewer gold
particles are seen in the granules of diabetic and insulin-treated tissue

(x 43,000; scale bar= 0.5 gm).

Figure 6. Immunogold labeling of acinar secretory granules with anti-RII
antibody.

(A.) Control, (B.) diabetic, (C.) insulin-treated diabetic rat. Very little
difference in reactivity of granules is seen between the control and diabetic
tissues. A greater decrease in reactivity is seen in the insulin-treated diabetic
tissue (x 43,000; scale bar= 0.5 gm).

Figure 7. Immunogold labeling of acinar nuclei with anti-RII antibody.

(A.) Control, (B.) diabetic, (C.) insulin-treated diabetic rat. Very little
difference in reactivity of nuclei is noted between the control and diabetic
tissues. A greater decrease is observed in the insulin-treated diabetic tissue

(x 43,000; scale bar= 0.5 gm).

Figure 8. Western blot of anti-SMG mucin.
Molecular weight standards (R) are shown in lane 1. Submandibular gland

(SMG) extracts are ghown in lanes 2-4. A mouse monoclonal antibody against
mucin recognized a single band of approximately 114 kD. (C) control, (D)

diabetic, (I) insulin-treated diabetic rats.

Figure 9. Western blot of anti-PRP.
Molecular weight standards (R) are shown in lane 1. Submandibular gland
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(SMG) extracts and parotid gland (PAR) extracts are shown in lanes 2-4 and
5-7, respectively. A rabbit polyclonal antibody against PRP recognized
several bands of approximately 25-35 kD. (C) control, (D) diabetic, (I)
insulin-treated diabetic rats.

Figure 10. Western blot of anti-RII.
Molecular weight standards (R) are shown in lane 1. Submandibular gland

(SMG) extracts and parotid gland (PAR) extracts are shown in lanes 2-4 and
5-7, respectively. A rabbit polyclonal antibody against RII recognized a
single band of approximately 50 kD. Several isoforms, RIIa and Rfr, were
also recognized. (C) control, (D) diabetic, (I) insulin-treated diabetic rats.

Figure 11. Densitometric scans of anti-SMG mucin in submandibular

gland extracts.

(A.) control, (B.) diabetic, (C.) insulin-treated diabetic rats. Note the
decrease in the integrated density of mucin in the diabetic group and its
reconstitution nearly to control levels in the insulin-treated diabetic group.

Figure 12. Densitometric scans of anti-PRP in submandiublar gland

extracts.

(A.) control, (B.) diabetic, (C.) insulin-treated diabetic rats. Note the
decrease in the integrated density of PRP in the diabetic group and its
reconstitution nearly to control levels in the insulin-treated diabetic group.

The protein expression of PRP in diabetes, however, was minimally reduced

(Table 4).
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Figure 13. Densitometric scans of anti-RII in submandibular

gland extracts.

(A.) control, (B.) diabetic, (C.) insulin-treated diabetic rats. Note the
decrease in the integrated density of RII in the diabetic group and its
reconstitution above control levels in the insulin-treated diabetic group. The

protein expression of RII in diabetes, however, was minimally reduced

(Table 4).

Figure 14. Densitometric scans of anti-PRP in parotid gland

extracts.

(A.) control, (B.) diabetic, (C.) insulin-treated diabetic rats. Note the
decrease in the integrated density of PRP in the diabetic group and its
reconstitution nearly to control levels in the insulin-treated diabetic group.

Figure 15. Densitometric scans of anti-RII in parotid gland

extracts.

(A.) control, (B.) diabetic, (C.) insulin-treated diabetic rats. Note the
decrease in the integrated density of RII in the diabetic group and its further

decrease in the insulin-treated diabetic group.
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